Developer docs
API playgroundTry for free, no card

Search company profiles

HumanFirst

Full company profile

uuid0003ayh

Namestring
HumanFirst
Legal namestring
HumanFirst (An ICON plc Company)
Company typeenum
Private
Founded yearint
2017
Descriptiontext

HumanFirst, founded in 2017 and now operating as a subsidiary of ICON plc, provides a cloud-based SaaS platform called Atlas that helps clinical researchers and care providers identify, evaluate, and deploy Digital Health Technologies (DHTs), digital biomarkers, and connected sensor technologies for decentralized and hybrid clinical trials. The platform's primary customers are pharmaceutical and biotechnology sponsors conducting clinical research, with secondary segments in clinical care delivery and public health organizations seeking validated remote monitoring tools. The Atlas platform consists of three components: Atlas Network, a discovery and evaluation catalog covering evidence, security, data rights, utility, usability, cost, and availability for each DHT; Atlas API, which enables technical customers and partners to build custom research tools on top of the platform; and the HumanFirst Institute, an educational and research arm offering courses, measure ontologies, and published research aimed at standardizing industry language around digital measures.

The platform is delivered as a multi-tenant SaaS product hosted on AWS, built on a defense-in-depth security architecture with customer isolation, encrypted data and backups, TLS-encrypted traffic, role- and permission-based access controls, and continuous monitoring. Its Information Security Program is guided by NIST CSF and aligned to SSAE SOC 2, with GDPR compliance for applicable jurisdictions. From a go-to-market standpoint, HumanFirst combines enterprise field sales to pharma and biotech (evidenced by demo request and ROI-focused case studies), a self-serve freemium tier under standard Terms for individual evaluators, and an API-first developer motion for technical integrations and partner-built tooling. Revenue is generated through annual enterprise subscription agreements with organizations, licensed data access, and professional services, all governed under ICON Clinical Research Limited's terms. As part of ICON plc, described as the world's leading clinical research organization, HumanFirst inherits global distribution reach into clinical trial sponsors and continues to operate the Atlas brand for existing customers.

Short descriptiontext

HumanFirst, an ICON plc company, provides the Atlas platform for pharmaceutical and biotechnology organizations to identify and evaluate Digital Health Technologies and digital biomarkers for decentralized clinical trials.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital health technology platform, clinical trial software, digital biomarker evaluation, decentralized clinical trials, remote patient monitoring
Industry2 codes
PRIMARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Technology / Digital Health Platform
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS Platform Subscription (Atlas)
TypeSubscription Recurring
Description

HumanFirst provides access to the HumanFirst Platform (Atlas) via subscription agreements. Customers access the platform, Licensed Data, and Solutions under commercial agreements. A free tier is available under standard Terms for individual customers without a separate commercial agreement; paid enterprise agreements are available for organizations.

gohumanfirst.com
2Licensed Data
TypeSubscription Recurring
Description

ICON compiles, collects, creates, or generates Licensed Data from various sources, maintained in the HumanFirst database and made available to customers through the platform or downloads. This data supports scientific research and pharmaceutical product development and may be delivered as part of the SaaS subscription or through separate data licensing agreements.

gohumanfirst.com
3Professional Services
TypeProfessional Services
Description

The Solutions may include professional services provided by ICON in addition to the core platform and Licensed Data, as indicated in the Terms definition of 'Solutions'.

gohumanfirst.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details2 tiers
1Free / Standard Terms Access
ModelFreemiumBilling cadenceAnnual
Notes

Free access under standard Terms for customers without a separate commercial Agreement. Includes access to the HumanFirst Platform and Licensed Data for the customer's own internal business purposes during the License Term.

gohumanfirst.com
2Enterprise / Organization Paid Agreement
ModelSubscriptionBilling cadenceAnnual
Notes

Custom paid agreements for organizations with separate written Agreements with ICON. Pricing and terms are negotiated via the organization's Agreement. Invoices due within 30 days of receipt; non-refundable payments in U.S. dollars.

gohumanfirst.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1Atlas Platform
Description

A platform for identifying and evaluating fit-for-purpose remote monitoring technologies across clinical research, clinical care, and public health. Includes Atlas Network and Atlas API.

gohumanfirst.com
+3 more records
Core offering1 text field

HumanFirst provides the Atlas platform — a cloud-based SaaS for identifying, evaluating, and deploying Digital Health Technologies (DHTs) and digital biomarkers across clinical research, clinical care, and public health. The offering is delivered as Atlas Network (a discovery and evaluation portal), Atlas API (programmatic access for custom research tools), and the HumanFirst Institute (courses, measure ontologies, and research), and is targeted at pharmaceutical, biotechnology, clinical care, and public health organizations.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

HumanFirst, now part of ICON plc, offers the Atlas platform—a unified suite for Digital Health Technologies (DHTs) and digital biomarkers. The platform consists of Atlas Network (the core evaluation and discovery platform for DHTs and digital biomarkers), Atlas API (for building custom research tools on top of the platform), and the HumanFirst Institute (providing educational courses, measure ontologies, and research publications). The HumanFirst Platform is the underlying SaaS infrastructure that delivers the Licensed Data to customers. The company was acquired by ICON, the world's leading clinical research organization, to expand ICON's digital health capabilities.

Product and service4 records
1Atlas Network
CategoryClinical Trial Technology Platform
Description

A discovery and evaluation portal that enables clinical researchers and care providers to identify and evaluate fit-for-purpose remote monitoring technologies, Digital Health Technologies (DHTs), and digital biomarkers across clinical research, clinical care, and public health. Targets pharma, biotech, clinical care, and public health organizations.

2Atlas API
CategoryDeveloper API / Platform Integration
Description

An API that allows technical customers and partners to build their own research tools on top of the Atlas platform, enabling custom integrations, applications, and programmatic access to Atlas evaluation data and capabilities.

3HumanFirst Platform
CategoryClinical Trial Technology Platform
Description

A software-as-a-service platform hosted by ICON that provides access to Licensed Data and the Atlas capabilities, enabling clinical researchers and care providers to identify connected sensor technologies that are high quality, effective, safe, and usable at home for clinical research, clinical care, and public health.

4HumanFirst Institute
CategoryEducation and Research Platform
Description

A learning and research platform within HumanFirst offering courses on enabling clinical research measures, measure ontologies for industry-wide language standardization, and research publications led or contributed to by the HumanFirst team. Supports adoption and thought leadership among clinical researchers and the broader digital health community.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Mapi Research Trust is ICON's affiliated research trust that is working closely with ICON and HumanFirst to build out additional capabilities that will further enhance the value derived from the Atlas platform. Mapi Research Trust and HumanFirst/ICON are collaborating on expanding the platform's evidence and insights capabilities for Atlas customers, representing a strategic co-development relationship within the ICON ecosystem.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Public cloud software company serving life sciences with Vault CTMS, EDC, and ePRO. Overlaps with HumanFirst on clinical operations data infrastructure and serves many of the same pharma decision-makers.

TypeDirect peer
Description

Decentralized clinical trial operator with a patient-facing platform and connected device orchestration. Comparable to HumanFirst in helping sponsors run technology-enabled home-based trials.

TypeEmerging player
Description

Cloud-based eClinical platform with growing DCT and device integration capabilities. Competes for the same mid-sized sponsor and academic CRO budget allocated to digital trial infrastructure.

TypeEmerging player
Description

DCT-focused CRO and technology provider offering connected device integration and remote monitoring for sponsors. Competes for the same decentralized trial engagements where DHT selection matters.

TypeDirect peer
Description

Specialist in eCOA, ePRO, and digital biomarker strategy for clinical research. Closely comparable to HumanFirst in serving pharma sponsors evaluating digital endpoints and connected sensors for trials.

TypeEmerging player
Description

DCT platform providing eCOA, telehealth, and connected device orchestration for hybrid trials. Overlaps with HumanFirst's DHT and digital biomarker evaluation layer for sponsor customers.

TypeDirect peer
Description

Industry-leading eClinical platform offering Rave EDC, eCOA, and a broad DHT module. Competes directly with HumanFirst in clinical trial digital measure infrastructure, though at much larger scale and with deeper sponsor integrations.

TypeEmerging player
Description

Decentralized clinical trial platform connecting sponsors with patients via eCOA, telehealth, and connected devices. Overlaps with HumanFirst's Atlas catalog by offering an integrated DHT selection and deployment workflow.

TypeDirect peer
Description

Direct competitor in eCOA/ePRO and connected device evidence generation for clinical trials. Competes with HumanFirst's Atlas evidence layer when sponsors evaluate endpoint strategies for decentralized studies.

TypeBroad incumbent
Description

Oracle's unified clinical trial suite (formerly goBalto/Informa) covering EDC, RTSM, and DCT. Competes as a broader incumbent sponsor-facing platform that increasingly bundles DHT and digital endpoint capabilities.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HumanFirst

Clinical Trial Technology / Digital Health Platformgohumanfirst.com

HumanFirst, an ICON plc company, provides the Atlas platform for pharmaceutical and biotechnology organizations to identify and evaluate Digital Health Technologies and digital biomarkers for decentralized clinical trials.

What HumanFirst does

HumanFirst, founded in 2017 and now operating as a subsidiary of ICON plc, provides a cloud-based SaaS platform called Atlas that helps clinical researchers and care providers identify, evaluate, and deploy Digital Health Technologies (DHTs), digital biomarkers, and connected sensor technologies for decentralized and hybrid clinical trials. The platform's primary customers are pharmaceutical and biotechnology sponsors conducting clinical research, with secondary segments in clinical care delivery and public health organizations seeking validated remote monitoring tools. The Atlas platform consists of three components: Atlas Network, a discovery and evaluation catalog covering evidence, security, data rights, utility, usability, cost, and availability for each DHT; Atlas API, which enables technical customers and partners to build custom research tools on top of the platform; and the HumanFirst Institute, an educational and research arm offering courses, measure ontologies, and published research aimed at standardizing industry language around digital measures.

The platform is delivered as a multi-tenant SaaS product hosted on AWS, built on a defense-in-depth security architecture with customer isolation, encrypted data and backups, TLS-encrypted traffic, role- and permission-based access controls, and continuous monitoring. Its Information Security Program is guided by NIST CSF and aligned to SSAE SOC 2, with GDPR compliance for applicable jurisdictions. From a go-to-market standpoint, HumanFirst combines enterprise field sales to pharma and biotech (evidenced by demo request and ROI-focused case studies), a self-serve freemium tier under standard Terms for individual evaluators, and an API-first developer motion for technical integrations and partner-built tooling. Revenue is generated through annual enterprise subscription agreements with organizations, licensed data access, and professional services, all governed under ICON Clinical Research Limited's terms. As part of ICON plc, described as the world's leading clinical research organization, HumanFirst inherits global distribution reach into clinical trial sponsors and continues to operate the Atlas brand for existing customers.

HumanFirst firmographics

Firmographics
Name
HumanFirst
Legal name
HumanFirst (An ICON plc Company)
Website
https://gohumanfirst.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
10,001+ employees
Short description
HumanFirst, an ICON plc company, provides the Atlas platform for pharmaceutical and biotechnology organizations to identify and evaluate Digital Health Technologies and digital biomarkers for decentralized clinical trials.
Ownership category
akta.pro rank

HumanFirst industry classification

Industry
Product category
Clinical Trial Technology / Digital Health Platform
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
SIC
Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Digital health technology platform
  • Clinical trial software
  • Digital biomarker evaluation
  • Decentralized clinical trials
  • Remote patient monitoring

Where HumanFirst is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

HumanFirst business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. SaaS Platform Subscription (Atlas): HumanFirst provides access to the HumanFirst Platform (Atlas) via subscription agreements. Customers access the platform, Licensed Data, and Solutions under commercial agreements. A free tier is available under standard Terms for individual customers without a separate commercial agreement; paid enterprise agreements are available for organizations.
  2. Licensed Data: ICON compiles, collects, creates, or generates Licensed Data from various sources, maintained in the HumanFirst database and made available to customers through the platform or downloads. This data supports scientific research and pharmaceutical product development and may be delivered as part of the SaaS subscription or through separate data licensing agreements.
  3. Professional Services: The Solutions may include professional services provided by ICON in addition to the core platform and Licensed Data, as indicated in the Terms definition of 'Solutions'.

Pricing tiers

ModelBillingPrice
FreemiumAnnualFree / Standard Terms Access
SubscriptionAnnualEnterprise / Organization Paid Agreement

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

HumanFirst product offering

Product offering

Core offering

HumanFirst provides the Atlas platform — a cloud-based SaaS for identifying, evaluating, and deploying Digital Health Technologies (DHTs) and digital biomarkers across clinical research, clinical care, and public health. The offering is delivered as Atlas Network (a discovery and evaluation portal), Atlas API (programmatic access for custom research tools), and the HumanFirst Institute (courses, measure ontologies, and research), and is targeted at pharmaceutical, biotechnology, clinical care, and public health organizations.

Product overview

HumanFirst, now part of ICON plc, offers the Atlas platform—a unified suite for Digital Health Technologies (DHTs) and digital biomarkers. The platform consists of Atlas Network (the core evaluation and discovery platform for DHTs and digital biomarkers), Atlas API (for building custom research tools on top of the platform), and the HumanFirst Institute (providing educational courses, measure ontologies, and research publications). The HumanFirst Platform is the underlying SaaS infrastructure that delivers the Licensed Data to customers. The company was acquired by ICON, the world's leading clinical research organization, to expand ICON's digital health capabilities.

Differentiator

Problem solved

Functional benefit

Brands

  • Atlas Platform: A platform for identifying and evaluating fit-for-purpose remote monitoring technologies across clinical research, clinical care, and public health. Includes Atlas Network and Atlas API.
  • Atlas Network
  • Atlas API
  • HumanFirst Institute

Products and services

  • Atlas Network A discovery and evaluation portal that enables clinical researchers and care providers to identify and evaluate fit-for-purpose remote monitoring technologies, Digital Health Technologies (DHTs), and digital biomarkers across clinical research, clinical care, and public health. Targets pharma, biotech, clinical care, and public health organizations.
  • Atlas API An API that allows technical customers and partners to build their own research tools on top of the Atlas platform, enabling custom integrations, applications, and programmatic access to Atlas evaluation data and capabilities.
  • HumanFirst Platform A software-as-a-service platform hosted by ICON that provides access to Licensed Data and the Atlas capabilities, enabling clinical researchers and care providers to identify connected sensor technologies that are high quality, effective, safe, and usable at home for clinical research, clinical care, and public health.
  • HumanFirst Institute A learning and research platform within HumanFirst offering courses on enabling clinical research measures, measure ontologies for industry-wide language standardization, and research publications led or contributed to by the HumanFirst team. Supports adoption and thought leadership among clinical researchers and the broader digital health community.

Companies that use HumanFirst

Customer profile

Segments3 records

Ideal customer profiles2 records

HumanFirst technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

HumanFirst partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Mapi Research TrustcoreStrategic or Co-development PartnerMapi Research Trust is ICON's affiliated research trust that is working closely with ICON and HumanFirst to build out additional capabilities that will further enhance the value derived from the Atlas platform. Mapi Research Trust and HumanFirst/ICON are collaborating on expanding the platform's evidence and insights capabilities for Atlas customers, representing a strategic co-development relationship within the ICON ecosystem.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

HumanFirst competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Public cloud software company serving life sciences with Vault CTMS, EDC, and ePRO. Overlaps with HumanFirst on clinical operations data infrastructure and serves many of the same pharma decision-makers.
  • Oracle Clinical One: Oracle's unified clinical trial suite (formerly goBalto/Informa) covering EDC, RTSM, and DCT. Competes as a broader incumbent sponsor-facing platform that increasingly bundles DHT and digital endpoint capabilities.

Direct peers

  • Science 37: Decentralized clinical trial operator with a patient-facing platform and connected device orchestration. Comparable to HumanFirst in helping sponsors run technology-enabled home-based trials.
  • Signant Health: Specialist in eCOA, ePRO, and digital biomarker strategy for clinical research. Closely comparable to HumanFirst in serving pharma sponsors evaluating digital endpoints and connected sensors for trials.
  • Medidata (Dassault Systèmes): Industry-leading eClinical platform offering Rave EDC, eCOA, and a broad DHT module. Competes directly with HumanFirst in clinical trial digital measure infrastructure, though at much larger scale and with deeper sponsor integrations.
  • Clario: Direct competitor in eCOA/ePRO and connected device evidence generation for clinical trials. Competes with HumanFirst's Atlas evidence layer when sponsors evaluate endpoint strategies for decentralized studies.

Emerging players

  • Castor: Cloud-based eClinical platform with growing DCT and device integration capabilities. Competes for the same mid-sized sponsor and academic CRO budget allocated to digital trial infrastructure.
  • ObvioHealth: DCT-focused CRO and technology provider offering connected device integration and remote monitoring for sponsors. Competes for the same decentralized trial engagements where DHT selection matters.
  • THREAD Research: DCT platform providing eCOA, telehealth, and connected device orchestration for hybrid trials. Overlaps with HumanFirst's DHT and digital biomarker evaluation layer for sponsor customers.
  • Medable: Decentralized clinical trial platform connecting sponsors with patients via eCOA, telehealth, and connected devices. Overlaps with HumanFirst's Atlas catalog by offering an integrated DHT selection and deployment workflow.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

HumanFirst social profiles

Digital presence

HumanFirst compliance and trust

Trust signal

Compliance3 records

HumanFirst financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HumanFirst leadership team

Management profile

Number of profiles

Profiles4 records

HumanFirst funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HumanFirst M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HumanFirst

What does HumanFirst do?

HumanFirst provides the Atlas platform — a cloud-based SaaS for identifying, evaluating, and deploying Digital Health Technologies (DHTs) and digital biomarkers across clinical research, clinical care, and public health. The offering is delivered as Atlas Network (a discovery and evaluation portal), Atlas API (programmatic access for custom research tools), and the HumanFirst Institute (courses, measure ontologies, and research), and is targeted at pharmaceutical, biotechnology, clinical care, and public health organizations.

Is HumanFirst a public or private company?

HumanFirst is a private company. It is classified as corporate owned and is currently operating.

When was HumanFirst founded?

HumanFirst was founded in 2017. It employs 10,001+ people.

Where is HumanFirst based?

HumanFirst is headquartered in San Francisco, United States, in the North America region.

How does HumanFirst make money?

Three revenue lines are on record. SaaS Platform Subscription (Atlas) is the primary driver. The others are licensed Data and professional Services.

Who are HumanFirst's main competitors?

Broad incumbents on record are Veeva Systems and Oracle Clinical One. Direct peers are Science 37, Signant Health, Medidata (Dassault Systèmes) and Clario. Emerging players are Castor, ObvioHealth, THREAD Research and Medable.

Does HumanFirst have an API?

Yes. Atlas API allows users to build their own research tools on top of the Atlas platform. The security documentation describes API security practices including strong authentication mechanisms, HTTPS/TLS connections, permission-based access controls, input validation, and rate limiting. Developer documentation is at www.gohumanfirst.com/atlas/api.

What industry is HumanFirst in?

HumanFirst's product category is Clinical Trial Technology / Digital Health Platform. Its primary akta.pro industry code is HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms, with a secondary code of HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices). Its NAICS code is 54171 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
STATIcon acquires HumanFirst to boost support for digital tools in clinical trialsIcon acquired HumanFirst, a company that provides digital measurement tools for clinical trials. The Atlas platform helps trial sponsors research tools for measuring physical activity or sleep. HumanFirst had raised $15 million in venture capital funding as of 2021.PR NewswireInsights From HumanFirst Show Breadth of Pharmaceutical Investment in AI/ML and Digital Endpoints in Clinical TrialsHumanFirst released an analysis showing over 130 pharmaceutical and biotech sponsors have used more than 1,300 AI-powered digital endpoints in clinical trials. The analysis finds 60% of these endpoints are secondary, and nearly two-thirds of trials are phase 2 or 4. The company cites an 11x increase in digital endpoint use over the past decade.PR NewswireHumanFirst Launches New Enterprise Platform to Accelerate Adoption of Precision Measures and Artificial Intelligence in Clinical ResearchHumanFirst launched a cloud-based enterprise platform for precision measures in clinical research, combining AI-powered biomarkers and clinical outcome assessments. The platform includes Atlas Network with over 7,500 pieces of evidence and 15,000+ digital measures, and aims to accelerate drug development and reduce costs.ForbesJoy Is Next Frontier Of Precision MedicinePrecision medicine researchers are exploring objective digital biomarkers to measure joy, happiness, and satisfaction alongside standard health metrics. Platforms like HumanFirst track over 840 sponsors and nearly 5,000 digital measures across 1,700 clinical trials. The goal is to expand drug development to better address human well-being.PR NewswireHumanFirst Offers Access to Industry's Largest Decentralized Clinical Trial DatabaseHumanFirst announced the launch of two new versions of its Atlas platform for decentralized clinical trials: AtlasPro for pharmaceutical and biotech researchers, and AtlasEDU, a free version for qualifying academic institutions. The platform contains over 2,000 digital health technologies covering more than 800 medical conditions and has been used by 22 of the 25 largest pharmaceutical companies and 23 of the top 50 academic institutions worldwide. The company positions the tools as ways to accelerate clinical trials and reduce costs, citing that pharmaceutical companies can lose an average of $3 million per day a drug is not on the market.ForbesMassive Digital Library Released To Accelerate Clinical Research And Cut CostsHumanFirst released AtlasEDU, a free platform for academic researchers to access its library of digital health measures. The platform covers 11,000+ measures across 800+ conditions, aiming to accelerate clinical study design and reduce costs. It is designed to improve inclusivity and trust in digital health products.PR NewswireHumanFirst Opens Up Atlas Platform to Scale Use of Decentralized Clinical TrialsHumanFirst, a healthcare technology company, announced the launch of OpenAtlas, a free tier of its Atlas platform that enables clinical study teams to evaluate and compare over 1,200 connected health technologies including wearables, sensors, and software-based evaluation tools for decentralized clinical trials. The platform addresses a critical gap in the clinical trials industry by providing detailed product information and comparison capabilities to help teams safely adopt digital monitoring tools, a practice accelerated by the COVID-19 pandemic's shift toward home and hybrid trial models. HumanFirst reports that 22 of the top 25 pharmaceutical companies have used its platform since its 2019 launch.PR NewswireHumanFirst and Duke Clinical Research Institute Collaborate to Improve Scientific Rigor for Digital MeasuresHumanFirst and the Duke Clinical Research Institute announced the creation of a Digital Measures Evaluation Center to assess sensors and digital measures used in clinical research. The center will leverage HumanFirst's Atlas platform and DCRI's trial design expertise to conduct technical and clinical evaluations on behalf of sponsor partners. The collaboration addresses the growing need for rigorous validation of digital measures as their adoption in decentralized and direct-to-patient trials continues to accelerate.PR NewswireHumanFirst Awarded as Technology Pioneer by World Economic ForumHumanFirst, a company specializing in decentralized clinical trials and distributed virtual healthcare, was selected by the World Economic Forum as one of its 100 Technology Pioneers for 2021. The company, formerly known as Elektra Labs, enables pharmaceutical companies to conduct clinical trials at home, reportedly serving 22 of the 25 leading pharmaceutical firms. As part of the recognition, HumanFirst CEO Andy Coravos will participate in Forum activities and contribute to initiatives addressing key healthcare and societal issues over the next two years.PR NewswireHumanFirst joins the FDA, HHS and more than 20 organizations and leading health companies to launch the Digital Health Measurement Collaborative Community (DATAcc)HumanFirst has joined the Digital Health Measurement Collaborative Community (DATAcc) alongside various health organizations and companies to establish best practices for measuring health through digital technologies. The collaborative aims to tackle challenges in digital health measurement, particularly in improving health outcomes and equity, especially against the backdrop of disparities exacerbated by COVID-19. The initiative is the first of its kind to convene a diverse group of stakeholders in this area.